Cardurion closes $260m in Series B to develop cardiovascular pipeline

The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart failure, and CRD-4730, a CaMKII inhibitor.

Jul 18, 2024 - 04:00
Cardurion closes $260m in Series B to develop cardiovascular pipeline
The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart failure, and CRD-4730, a CaMKII inhibitor.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow